A Study to Evaluate the Progression of Gastrointestinal and Fatigue Symptoms in the Scleroderma Population Seen at Mayo Clinic Arizona


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Scottsdale/Phoenix, Arizona: 16-006841
    Sponsor Protocol Number: 16-006841

About this study

The purpose of this study is to evaluate the progression of gastrointestinal and fatigue symptoms over time (approximately 5 years) in the scleroderma population seen at Mayo Clinic Arizona.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria 

  • Adult
  • Has scleroderma 
  • Has previously completed the questionnaire packet

Exclusion Criteria

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Sarah Umar, M.D.

Open for enrollment

Contact information:

Michael Crowell Ph.D.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer